Annual CFI
$257.63 M
+$446.38 M+236.50%
December 31, 2023
Summary
- As of February 7, 2025, RLAY annual cash flow from investing activities is $257.63 million, with the most recent change of +$446.38 million (+236.50%) on December 31, 2023.
- During the last 3 years, RLAY annual CFI has risen by +$175.96 million (+215.45%).
- RLAY annual CFI is now at all-time high.
Performance
RLAY Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$126.16 M
-$171.71 M-376.97%
September 1, 2024
Summary
- As of February 7, 2025, RLAY quarterly cash flow from investing activities is -$126.16 million, with the most recent change of -$171.71 million (-376.97%) on September 1, 2024.
- Over the past year, RLAY quarterly CFI has dropped by -$197.53 million (-276.78%).
- RLAY quarterly CFI is now -243.94% below its all-time high of $87.65 million, reached on June 30, 2020.
Performance
RLAY Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$10.40 M
-$197.53 M-105.56%
September 1, 2024
Summary
- As of February 7, 2025, RLAY TTM cash flow from investing activities is -$10.40 million, with the most recent change of -$197.53 million (-105.56%) on September 1, 2024.
- Over the past year, RLAY TTM CFI has dropped by -$61.42 million (-120.39%).
- RLAY TTM CFI is now -104.04% below its all-time high of $257.63 million, reached on December 31, 2023.
Performance
RLAY TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
RLAY Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +236.5% | -276.8% | -120.4% |
| 3 y3 years | +215.4% | -706.9% | +96.0% |
| 5 y5 years | +10000.0% | -1883.0% | +96.7% |
RLAY Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +153.7% | -267.5% | +56.9% | -104.0% | +97.8% |
| 5 y | 5-year | at high | +153.7% | -243.9% | +56.9% | -104.0% | +97.8% |
| alltime | all time | at high | +153.7% | -243.9% | +64.8% | -104.0% | +97.8% |
Relay Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$126.16 M(-377.0%) | -$10.40 M(-105.6%) |
| Jun 2024 | - | $45.55 M(+332.5%) | $187.12 M(-3.0%) |
| Mar 2024 | - | $10.53 M(-82.4%) | $192.85 M(-25.1%) |
| Dec 2023 | $257.63 M(-236.5%) | $59.68 M(-16.4%) | $257.63 M(+405.0%) |
| Sep 2023 | - | $71.36 M(+39.2%) | $51.02 M(+645.7%) |
| Jun 2023 | - | $51.28 M(-31.9%) | $6.84 M(-753.5%) |
| Mar 2023 | - | $75.31 M(-151.3%) | -$1.05 M(-99.4%) |
| Dec 2022 | -$188.75 M(-60.6%) | -$146.94 M(-640.5%) | -$188.75 M(-43.6%) |
| Sep 2022 | - | $27.19 M(-37.3%) | -$334.55 M(-1.9%) |
| Jun 2022 | - | $43.39 M(-138.6%) | -$340.95 M(-4.8%) |
| Mar 2022 | - | -$112.38 M(-61.6%) | -$358.27 M(-25.3%) |
| Dec 2021 | -$479.51 M | -$292.75 M(-1508.3%) | -$479.51 M(+82.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $20.79 M(-20.3%) | -$263.19 M(-0.3%) |
| Jun 2021 | - | $26.07 M(-111.2%) | -$263.90 M(+30.4%) |
| Mar 2021 | - | -$233.62 M(+205.7%) | -$202.32 M(-347.7%) |
| Dec 2020 | $81.67 M(-125.6%) | -$76.42 M(-480.7%) | $81.67 M(-57.9%) |
| Sep 2020 | - | $20.07 M(-77.1%) | $193.99 M(+7.2%) |
| Jun 2020 | - | $87.65 M(+74.0%) | $180.99 M(-168.2%) |
| Mar 2020 | - | $50.37 M(+40.3%) | -$265.51 M(-16.8%) |
| Dec 2019 | -$319.02 M(>+9900.0%) | $35.90 M(+407.3%) | -$319.02 M(-10.1%) |
| Sep 2019 | - | $7.08 M(-102.0%) | -$354.92 M(-2.0%) |
| Jun 2019 | - | -$358.85 M(>+9900.0%) | -$362.00 M(>+9900.0%) |
| Mar 2019 | - | -$3.14 M | -$3.14 M |
| Dec 2018 | -$1.68 M | - | - |
FAQ
- What is Relay Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Relay Therapeutics?
- What is Relay Therapeutics annual CFI year-on-year change?
- What is Relay Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Relay Therapeutics?
- What is Relay Therapeutics quarterly CFI year-on-year change?
- What is Relay Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Relay Therapeutics?
- What is Relay Therapeutics TTM CFI year-on-year change?
What is Relay Therapeutics annual cash flow from investing activities?
The current annual CFI of RLAY is $257.63 M
What is the all time high annual CFI for Relay Therapeutics?
Relay Therapeutics all-time high annual cash flow from investing activities is $257.63 M
What is Relay Therapeutics annual CFI year-on-year change?
Over the past year, RLAY annual cash flow from investing activities has changed by +$446.38 M (+236.50%)
What is Relay Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of RLAY is -$126.16 M
What is the all time high quarterly CFI for Relay Therapeutics?
Relay Therapeutics all-time high quarterly cash flow from investing activities is $87.65 M
What is Relay Therapeutics quarterly CFI year-on-year change?
Over the past year, RLAY quarterly cash flow from investing activities has changed by -$197.53 M (-276.78%)
What is Relay Therapeutics TTM cash flow from investing activities?
The current TTM CFI of RLAY is -$10.40 M
What is the all time high TTM CFI for Relay Therapeutics?
Relay Therapeutics all-time high TTM cash flow from investing activities is $257.63 M
What is Relay Therapeutics TTM CFI year-on-year change?
Over the past year, RLAY TTM cash flow from investing activities has changed by -$61.42 M (-120.39%)